C
LABU icon

Covestor’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

Covestor’s Portfolio LABU Stock Details LABU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$119K Buy
719
+271
+60% +$44.5K 0.08% 220
2025
Q4 		$71K Buy
+448
New +$61.5K 0.04% 759

Other funds holding LABU

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
JF
Jump Financial Chicago, Illinois $7.5B AUM 33.9% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
MIG
McGuire Investment Group Wakefield, Rhode Island $885M AUM 47.78% 1-Year Est. Return
Belvedere Trading
Belvedere Trading Chicago, Illinois $84.4B AUM 52.68% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Covestor's LABU Position: Q1 2026 in Review

Covestor increased its Direxion Daily S&P Biotech Bull 3X ETF (LABU) stake by 60% in Q1 2026, buying an estimated $44.5K and bringing the position to 719 shares worth $119K. The position accounts for 0.08% of the portfolio, ranked #220.

Covestor first reported a position in LABU in Q4 2025 and has held it in 2 quarters since. 33 funds tracked by Wall St. Rank hold LABU as of Q1 2026.

  • Covestor held 719 shares of Direxion Daily S&P Biotech Bull 3X ETF worth $119K as of Q1 2026.
  • Covestor bought 271 Direxion Daily S&P Biotech Bull 3X ETF shares in Q1 2026, an estimated $44.5K.
  • Direxion Daily S&P Biotech Bull 3X ETF made up 0.08% of Covestor's portfolio in Q1 2026, its #220 holding.
  • Covestor first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q4 2025 and has held it in 2 quarters since.
  • 33 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q1 2026.

Based on Covestor's 13F filing for Q1 2026, filed 5 May 2026.